Hormone replacement therapy that combines estrogen and progestin doubles a woman 's risk of breast cancer , a British study of more than a million women finds .
A major British study adds to the evidence that hormone replacement therapy increases the risk of breast cancer , especially when women receive a combination of estrogen and progestin .